How about the feasibility of endoscopic ultrasonography-guided choledochoduodenostomy?

October 31, 2008

Endoscopic ultrasonography (EUS)-guided biliary drainage for treatment of patients who have obstructive jaundice in cases of failed endoscopic retrograde cholangiopancreatography (ERCP).

An article to be published on October 21, 2008 in the World Journal of Gastroenterology addresses the case. The research team led by Takao Itoi, from Tokyo Medical University Shinjuku-ku of Japan introduced the feasibility and outcome of EUS-guided choledochoduodenostomy in four patients who failed ERCP.

They performed the procedure in 2 papilla of Vater, including one resectable case, and 2 cases of cancer of the head of pancreas were applied for this procedure. Using a curved linear array echoendoscope, a 19 G needle or a needle knife was punctured transduodenally into the bile duct under EUS visualization. After using a biliary catheter for dilation, or papillary balloon dilator, a 7-Fr plastic stent was inserted through the choledochoduodenostomy site into the extrahepatic bile duct. In 3 of 4 (75%) cases, an indwelling plastic stent was placed, and in one case in which the stent could not be advanced into the bile duct, a naso-biliary drainage tube was placed instead.

In all cases, the obstructive jaundice rapidly improved after the procedure. Focal peritonitis and bleeding not requiring blood transfusion was seen in one cases. In this case, pancreatoduodenectomy was perfomed and the surgical findings revealed that severe adhesion around the choledochoduodenostomy site was recognized. Although further studies and development of devices are mandatory, EUS-guided choledochoduodenostomy may appear to be an effective alternative to ERCP in selected cases.
-end-
Reference: Itoi T, Itokawa F, Sofuni A, Kurahara T, Tsuchiya T, Ishii K, Tsuji S, Ikeuchi N, Moriyasu F. World J Gastroenterol 2008; 14(39): 6078-6082 http://www.wjgnet.com/1007-9327/14/6078.asp

Correspondence to: Takao Itoi, MD, Department of Gastroenterology and Hepatology, Tokyo Medical University Shinjuku-ku, Nishishinjuku 6-7-1, Tokyo 160-0023, Japan. itoi@tokyo-med.ac.jp Telephone: +81-3-33426111 Fax: +81-3-53816654

About World Journal of Gastroenterology

World Journal of Gastroenterology (WJG), a leading international journal in gastroenterology and hepatology, has established a reputation for publishing first class research on esophageal cancer, gastric cancer, liver cancer, viral hepatitis, colorectal cancer, and H pylori infection. It provides a forum for both clinicians and scientists. WJG has been indexed and abstracted in Current Contents/Clinical Medicine, Science Citation Index Expanded (also known as SciSearch) and Journal Citation Reports/Science Edition, Index Medicus, MEDLINE and PubMed, Chemical Abstracts, EMBASE/Excerpta Medica, Abstracts Journals, Nature Clinical Practice Gastroenterology and Hepatology, CAB Abstracts and Global Health. ISI JCR 2003-2000 IF: 3.318, 2.532, 1.445 and 0.993. WJG is a weekly journal published by WJG Press. The publication dates are the 7th, 14th, 21st, and 28th of every month. The WJG is supported by The National Natural Science Foundation of China, No. 30224801 and No. 30424812, and was founded with the title China National Journal of New Gastroenterology on October 1, 1995, and renamed WJG on January 25, 1998.

About The WJG Press

The WJG Press mainly publishes World Journal of Gastroenterology.

World Journal of Gastroenterology

Related Stent Articles from Brightsurf:

In-stent thrombosis after antiplatelet therapy conversion while awaiting coronary bypass
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0589, Nathan Burke, Tawanna Charlton, Hussam Hawamdeh, and Ki Park from the University of Florida College of Medicine, Gainesville, Florida, USA consider a case study of in-stent thrombosis after antiplatelet therapy conversion while awaiting coronary bypass.

Late coronary stent thrombosis in patient with COVID-19
This case report describes a patient with COVID-19 who developed late drug-eluting stent thrombosis.

Randomization of provisional vs two-stent techniques in complex bifurcation lesions
Aim: The present study aimed to assess the benefits of two-stent techniques for patients with DEFINITION criteria-defined complex coronary bifurcation lesions.

Leg pain medication may prevent re-blockage of neck arteries after a stent
Adding cilostazol, an antiplatelet medication for leg pain, to other drugs tended to prevent re-blockage of carotid artery stents within two years.

The world's smallest stent
Researchers at ETH Zurich have developed a new method for producing malleable microstructures -- for instance, vascular stents that are 40 times smaller than previously possible.

Type of stent affects immediate and long-term outcomes
A new study comparing the outcomes of different types of stents used to treat cerebral aneurysms shows that the type of stent used affects a patient's immediate and long-term health outcomes.

Stopping DAPT after one-month improved outcomes in stent patients
Patients who stopped taking aspirin one month after receiving a stent in the heart's arteries but continued taking the P2Y12 inhibitor clopidogrel fared significantly better after one year compared with those who followed the standard practice of continuing both medications, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Sugary stent eases suturing of blood vessels
A team led by the University of Nebraska-Lincoln and Harvard Medical School has concocted a sugar-heavy stent to reduce the margin of error in a delicate surgical procedure.

Non-invasive stent monitoring techniques tested
Barcelona researchers develop a probe to detect and monitor metallic stents.

Stent retriever thrombectomy effective for longer window after stroke
A new study shows promising real-world outcomes for patients receiving a stent retriever thrombectomy six hours after they experience an acute ischemic stroke (AIS).

Read More: Stent News and Stent Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.